日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial network

欧洲淋巴管肌瘤病诊疗服务可及性:ERN-LUNG临床实践调查,以及建立欧洲注册登记和试验网络的必要性

O'Malley, Donal; Humbert-Dorfmüller, Elisabeth; Barberà, Joan A; van Batenburg, Aernoud; Bendstrup, Elisabeth; Cottin, Vincent; Elia, Davide; Froidure, Antoine; Grutters, Jan; Harari, Sergio; Hernandez-Gonzalez, Fernanda; Kokosi, Maria; Lund, Thomas Kromann; Manali, Effrosyni D; Meszaros, Gergely; van Pottelberge, Geert; Radzikowska, Elzbieta; Sellares, Jacobo; Svenningsson, Anna; Veltkamp, Marcel; Wagner, Thomas; Hebestreit, Helge; McCarthy, Cormac

Acceptability and Determinants for Implementation of the EnzySystem, a Novel Near-Patient Testing Platform for Haemophilia A

EnzySystem(一种新型的甲型血友病床旁检测平台)的可接受性及其实施决定因素

Bavinck, Aernoud P; Davis, Kyle; van Engelshoven, Lisa; van Lier, Monique G; Hamacher, Tanja; Blijlevens, Nicole M A; Shapiro, Amy; Schols, Saskia E M; van Heerde, Waander L

Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti-Fibrotic Treatment: Real-World Data From the Dutch National Registry

肺纤维化患者开始抗纤维化治疗后肺功能的变化过程:来自荷兰国家注册中心的真实世界数据

Platenburg, Mark G J P; Nakshbandi, Gizal; Moor, Catharina C; van Batenburg, Aernoud A; Mostard, Rémy L M; Voortman, Mareye; Moonen, Linda A A; Hekelaar, Nicolle; Overbeek, Maria J; A H A Bogaarts, Brigitte; Kramer, Henk; Marges, Emiel R; Boerrigter, Bart B; Bresser, Paul; Schakenraad, Eveline L; van der Maten, Jan; van der Sloot, Niels C A; Walen, Stefan; Afonso, Pedro Miranda; Wijsenbeek, Marlies S; Grutters, Jan C

Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial

慢性冠状动脉疾病患者永久停止试验药物治疗的性别差异:LoDoCo2试验

van der Bijl, Marte F; van der Veen, Jenny; Fiolet, Aernoud T L; Boersma, Eric; Cornel, Jan H; Eikelboom, John W; Nidorf, Stefan M; Thompson, Peter L; Jannink, Jalina; Westendorp, Iris C D; Mosterd, Arend; den den Ruijter, Hester M; Roeters van Lennep, Jeanine E

Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands

荷兰慢性冠心病患者低剂量秋水仙碱的成本效益分析

Fiolet, Aernoud T L; Keusters, Willem; Blokzijl, Johan; Nidorf, S Mark; Eikelboom, John W; Budgeon, Charley A; Tijssen, Jan G P; Römer, Tjeerd; Westendorp, Iris; Cornel, Jan Hein; Thompson, Peter L; Frederix, Geert W J; Mosterd, Arend; de Wit, G Ardine

Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review

即时检测在遗传性原发性止血障碍患者中的应用:叙述性综述

Bavinck, Aernoud P; Heerde, Waander van; Schols, Saskia E M

The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists

秋水仙碱对使用维生素K拮抗剂的慢性冠心病患者凝血功能的影响

Houwen, Jeroen P A; Lalmohamed, Arief; Zwaan, Jochem; Egberts, Toine C G; Duyvendak, Michiel; Fiolet, Aernoud T L; Mosterd, Arend

Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

利用新型即时检测平台(EnzySystem HemA)同时测量FVIII活性和凝血酶生成:定性可用性评估

Bavinck, Aernoud; Schols, Saskia E M; Teunissen, Wilfred; Shapiro, Amy; Blijlevens, Nicole M A; Davis, Kyle; van Heerde, Waander

Chances and challenges of questionnaires in heart failure care

问卷调查在心力衰竭护理中的机遇与挑战

Fiolet, Aernoud T L; Szymanski, Mariusz K

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial

秋水仙碱对心血管获益与基线风险的关系:LoDoCo2试验的二次分析

Mohammadnia, Niekbachsh; Wesselink, Britta E; Bax, Willem A; Nidorf, Stefan M; Mosterd, Arend; Fiolet, Aernoud T L; Cetinyurek-Yavuz, Aysun; Thompson, Peter L; Bangdiwala, Shrikant I; Eikelboom, John W; Cornel, Jan H; El Messaoudi, Saloua